GlassScriptPhysician profile
David N Prall
NPI 1356549638
$2,731.48
in general payments reported to CMS, 2019-2025
27 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,243 · 2020: $70.06 · 2021: $58.70 · 2022: $199 · 2023: $267 · 2024: $427 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,313.46 | 2019-2020 | |
| Coloplast Corp | $268.06 | 2022-2025 | Speedicath |
| Teleflex LLC | $261.45 | 2021-2025 | Urolift, Barrigel |
| Calyxo, INC. | $138.59 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $90.06 | 2022-2025 | Xyosted |
| Janssen Biotech, INC. | $75.72 | 2022-2025 | Erleada, Balversa |
| Astellas Pharma US INC | $59.63 | 2024-2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $50.52 | 2024-2025 | |
| Angiodynamics, INC. | $45.73 | 2024 | Nanoknife |
| Boston Scientific Corporation | $44.88 | 2025 | Axonics |
| Olympus America INC. | $42.01 | 2023-2025 | Itind System |
| Srs Medical Systems, INC. | $40.25 | 2022 | |
| Sumitomo Pharma America, INC. | $35.26 | 2024-2025 | Orgovyx |
| Halozyme INC | $29.44 | 2023 | |
| Becton, Dickinson and Company | $29.41 | 2025 | Magic3 Intermittent Catheter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27.57 | 2025 | Lynparza |
| Immunitybio, INC. | $20.68 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.48 | 2025 | |
| Convatec INC. | $18.23 | 2023 | |
| Urogen Pharma, INC. | $16.59 | 2024 | |
| Abc Home Medical Supply, INC. | $16.17 | 2025 | |
| 180 Medical, INC. | $15.35 | 2025 | |
| Amgen INC. | $14.96 | 2023 | Prolia |
| Abbvie INC. | $14.67 | 2023 | |
| Photocure INC | $14.47 | 2024 | Cysview |
| Pfizer INC. | $14.47 | 2024 | |
| Tolmar, INC. | $13.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Prall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.